DRUG · Mapped RxNorm record
Paliperidone Palmitate
Normalized identity: paliperidone palmitateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
NCT01947803
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
Paliperidone PalmitateDRUG · verified · RxNorm: paliperidone palmitate
Sponsors & collaborators
Xian-Janssen Pharmaceutical Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01947803 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.